Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.
NCT03556800
Viramal LimitedMenopause
Start: 2018-05-22End: 2022-06-30Target: 20Updated: 2022-04-27